MicroRNA‐mediated metabolic reprogramming of chimeric antigen receptor T cells

Advances made in chimeric antigen receptor (CAR) T cell therapy have revolutionized the treatment and management of certain cancers. Currently, B cell malignancies have been among the few cancers to which CAR T cells have shown persistent and resilient anti‐tumor responses. A growing body of evidenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Rad, Seyed Mohammad Ali Hosseini, Halpin, Joshua Colin, Tawinwung, Supannikar, Suppipat, Koramit, Hirankarn, Nattiya, McLellan, Alexander D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322280/
https://www.ncbi.nlm.nih.gov/pubmed/35507473
http://dx.doi.org/10.1111/imcb.12551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322280/
https://www.ncbi.nlm.nih.gov/pubmed/35507473
http://dx.doi.org/10.1111/imcb.12551

Ejemplares similares